Table 2.
Descriptive statistics of NAD+, NMN, and NR measured for cancer patients.
| N | Mean | SD | Median | Min | Max | |
|---|---|---|---|---|---|---|
| Age | 91 | 69.8 | 10.69 | 72 | 40 | 93 |
| RBC (106 cells/µL) | 91 | 4.26 | 0.59 | 4.35 | 2.91 | 5.91 |
| MCV (fL) | 90 | 91.75 | 6.48 | 92.45 | 69.1 | 104.5 |
| Concentration in whole blood | ||||||
| NAD+ (µM) | 91 | 22.00 | 4.37 | 21.66 | 9.8 | 31.85 |
| NMN (µM) | 91 | 1.34 | 0.44 | 1.35 | 0.35 | 2.4 |
| NR (µM) | 91 | 0.04 | 0.02 | 0.04 | 0.01 | 0.15 |
| Concentration in RBCs | ||||||
| NAD+ (µM) | 90 | 57.06 | 10.9 | 56.91 | 28.08 | 85.03 |
| NMN (µM) | 90 | 3.49 | 1.23 | 3.48 | 0.8 | 6.76 |
| NR (µM) | 90 | 0.11 | 0.05 | 0.1 | 0.02 | 0.34 |
MCV, mean corpuscular volume; NAD+, nicotinamide adenine dinucleotide; NMN, nicotinamide mononucleotide; NR, nicotinamide riboside chloride; RBC, red blood cell.